Also known as: Bronchial Asthma
Asthma is a chronic respiratory condition in which the airways become inflamed and narrowed, making it difficult to breathe.
Asthma is a chronic inflammatory disorder of the airways affecting an estimated 339 million people worldwide. It is characterized by reversible airway obstruction, bronchial hyperresponsiveness, and underlying inflammation that causes the airways to swell, produce excess mucus, and narrow in response to various triggers. The result is recurrent episodes of wheezing, breathlessness, chest tightness, and coughing that vary in severity and frequency from person to person.
Asthma is a heterogeneous disease with multiple phenotypes. Allergic asthma, the most common form, is driven by IgE-mediated immune responses to environmental allergens and typically begins in childhood. Non-allergic asthma may be triggered by respiratory infections, exercise, cold air, stress, or irritants. Other phenotypes include exercise-induced bronchoconstriction, occupational asthma triggered by workplace exposures, and aspirin-exacerbated respiratory disease. Severe asthma, affecting approximately 5-10% of patients, is characterized by persistent symptoms despite high-dose controller therapy.
The pathophysiology of asthma involves chronic airway inflammation driven by multiple cell types including eosinophils, mast cells, T lymphocytes, and neutrophils. This inflammation leads to structural changes in the airway walls called airway remodeling, which includes thickening of the basement membrane, smooth muscle hypertrophy, and goblet cell hyperplasia. Early diagnosis, appropriate treatment with controller medications, trigger avoidance, and regular monitoring are essential to prevent irreversible airway changes and maintain optimal lung function throughout life.
People with Asthma often experience the following symptoms.
A high-pitched whistling sound produced during breathing, particularly exhalation, caused by air flowing through narrowed airways. Wheezing is one of the most recognizable asthma symptoms but may be absent during severe attacks when airflow is severely restricted.
Difficulty breathing or a sensation of not getting enough air, which can range from mild breathlessness with exertion to severe respiratory distress at rest during an acute attack. Patients often describe it as a feeling of air hunger or chest heaviness.
A squeezing or constricting sensation in the chest caused by bronchospasm and airway inflammation. This symptom can be frightening and is sometimes mistaken for cardiac chest pain, particularly in adults experiencing asthma for the first time.
A persistent cough, often worse at night or early morning, is a common and sometimes the only symptom of asthma (cough-variant asthma). The cough may be dry or produce small amounts of clear mucus and can be triggered by cold air, exercise, or allergen exposure.
Asthma symptoms frequently worsen at night due to circadian variations in airway tone, increased allergen exposure in the bedroom, and recumbent position. Nocturnal awakenings from cough, wheezing, or breathlessness are indicators of inadequately controlled asthma.
Physical exertion can trigger bronchoconstriction, causing coughing, wheezing, and shortness of breath during or shortly after exercise. Exercise-induced bronchoconstriction affects up to 90% of people with asthma and can also occur as an isolated condition in otherwise healthy individuals.
Inflamed airways produce excess thick, sticky mucus that further narrows the airways and contributes to coughing and breathing difficulty. During severe exacerbations, mucus plugging of the airways can significantly worsen airflow obstruction.
Certain factors may increase your likelihood of developing Asthma.
Common approaches to managing asthma. Always consult a healthcare provider for personalized treatment.
Inhaled corticosteroids such as fluticasone, budesonide, and beclomethasone are the cornerstone of asthma management. Used daily, they reduce airway inflammation, decrease symptom frequency, improve lung function, and reduce the risk of severe exacerbations. Consistent use is essential even when feeling well.
Short-acting beta-2 agonists like albuterol (salbutamol) provide rapid relief of acute symptoms by relaxing airway smooth muscle. They should be used as needed for symptom relief but frequent use (more than twice weekly) indicates the need for better controller therapy.
Long-acting beta-2 agonists (LABAs) such as formoterol and salmeterol are always used in combination with inhaled corticosteroids for moderate to severe asthma. Combination inhalers (ICS/LABA) such as fluticasone/salmeterol and budesonide/formoterol simplify treatment and improve adherence.
For severe asthma not controlled by standard medications, biologic drugs targeting specific inflammatory pathways are available. These include omalizumab (anti-IgE), mepolizumab and benralizumab (anti-IL-5/anti-IL-5R), and dupilumab (anti-IL-4R). They are administered by injection and can dramatically reduce exacerbations.
A written asthma action plan developed with your doctor outlines daily treatment, how to recognize worsening symptoms, and when to seek emergency care. Regular peak flow monitoring and symptom tracking empower patients to adjust treatment appropriately and prevent severe attacks.
Identifying and minimizing exposure to personal asthma triggers is a fundamental component of management. Common triggers include allergens, respiratory infections, exercise, cold air, tobacco smoke, air pollution, strong odors, and certain medications like aspirin and beta-blockers.
Asthma is diagnosed through a combination of clinical history, physical examination, and objective lung function testing. Spirometry is the primary diagnostic test, measuring the volume and speed of air that can be exhaled. A key finding is a reduced FEV1/FVC ratio (the proportion of air exhaled in the first second compared to total exhaled volume) that improves by at least 12% and 200 mL after inhaling a bronchodilator, demonstrating the reversible airway obstruction characteristic of asthma. If spirometry is normal but asthma is still suspected, bronchial provocation testing with methacholine or exercise can reveal airway hyperresponsiveness. Peak expiratory flow (PEF) variability measured over 2-4 weeks may also support the diagnosis. Additional tests including fractional exhaled nitric oxide (FeNO), blood eosinophil counts, and allergy testing help characterize the asthma phenotype and guide treatment decisions.
Seek emergency medical care if you experience severe shortness of breath that makes it difficult to walk or talk, your lips or fingernails turn blue, your rescue inhaler provides no relief, or your peak flow meter readings drop below 50% of your personal best. Call for emergency assistance if breathing difficulty is rapidly worsening or you feel extreme anxiety about being unable to breathe. Any asthma attack that does not respond to a rescue inhaler requires immediate medical attention.
Steps that may help reduce the risk of developing or worsening asthma.
Identify and avoid personal asthma triggers including allergens, irritants, and environmental conditions that worsen your symptoms
Take prescribed controller medications consistently as directed, even during symptom-free periods, to maintain airway health and prevent exacerbations
Get an annual influenza vaccine and stay current with pneumococcal and COVID-19 vaccinations, as respiratory infections are major triggers for asthma attacks
Maintain a smoke-free home and avoid exposure to secondhand smoke, which can damage airways and trigger asthma symptoms
Monitor air quality reports and limit outdoor activities during high pollution or high pollen days, using air conditioning and HEPA filters indoors
If left untreated or poorly managed, asthma may lead to:
Some children with asthma experience significant improvement or complete remission of symptoms during adolescence. However, asthma can return later in life, and the underlying airway hyperresponsiveness may persist even when symptoms are absent. Adults rarely outgrow asthma. Regular follow-up with a healthcare provider is important even if symptoms have resolved, particularly before discontinuing controller medications.
Yes, and regular exercise is actually recommended for people with asthma. Well-controlled asthma should not prevent physical activity. Exercise-induced bronchoconstriction can be prevented by using a rescue inhaler 15-20 minutes before exercise, performing a proper warm-up, and choosing activities in warm, humid environments when possible. Swimming is often well-tolerated. If exercise consistently triggers symptoms, your controller therapy may need adjustment.
Controller inhalers (typically containing inhaled corticosteroids) are used daily to reduce underlying airway inflammation and prevent symptoms. They work gradually and do not provide immediate relief. Rescue inhalers (short-acting bronchodilators like albuterol) quickly relax airway muscles to provide rapid relief during an acute attack. Both types are essential — controllers prevent attacks while rescue inhalers treat breakthroughs. Needing your rescue inhaler more than twice a week suggests your controller therapy needs adjustment.
For most people, asthma is a chronic lifelong condition that requires ongoing management. While symptoms may fluctuate in severity over time, the underlying airway inflammation and hyperresponsiveness tend to persist. The good news is that with proper treatment, most people with asthma can achieve excellent symptom control, maintain normal lung function, and lead fully active lives. Advances in biologic therapies have also dramatically improved outcomes for those with severe asthma.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.